Zydus Wellness · NSE: ZYDUSWELL · BSE: 531335
Q4 FY25 results · Jan–Mar 2025
Zydus Wellness reported revenue from operations of ₹913.10 crore (up 16.7% from Q4 FY24) and net profit of ₹171.90 crore (up 14.4% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 913.10 | 782.60 | +16.7% | 461.90 | +97.7% |
| Other income | 0.80 | 4.00 | −80.0% | 3.80 | −78.9% |
| Total income | 913.90 | 786.60 | +16.2% | 465.70 | +96.2% |
| Profit before tax | 173.40 | 154.40 | +12.3% | 10.10 | 17x |
| Net profit for the period | 171.90 | 150.30 | +14.4% | 6.40 | 27x |
| EPS, basic (₹) | 27.01 | 23.62 | +14.4% | 1.01 | 27x |
| Net margin (%) | 18.8 | 19.2 | 1.4 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 77.50 | 63.10 | +22.8% | 88.40 | −12.3% |
| Other income | 0.30 | 4.70 | −93.6% | 3.10 | −90.3% |
| Total income | 77.80 | 67.80 | +14.7% | 91.50 | −15.0% |
| Profit before tax | 6.20 | 10.40 | −40.4% | 15.60 | −60.3% |
| Net profit for the period | 4.70 | 7.40 | −36.5% | 11.70 | −59.8% |
| EPS, basic (₹) | 0.74 | 1.16 | −36.2% | 1.84 | −59.8% |
| Net margin (%) | 6.1 | 11.7 | 13.2 |
Consolidated
- Filed with BSE
- 19 May 2025, 20:57 IST
- Board meeting
- 19 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 19 May 2025, 20:57 IST
- Board meeting
- 19 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE